Obstructive Pulmonary Disease
16
2
2
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
Measurement of Viscoelastic Properties of Bronchopulmonary Secretions.
Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans
French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease
Improving Patient Prioritization During Hospital-homecare Transition
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
AECOPD and Nutritional Supplementation in COPD
Cardio-pulmonary Rehabilitation and Sleep Quality
FCV Vs VCV in Obstructive and Asthmatic Patients
The Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
Gut Microbiota in Chronic Noncommunicable Diseases
Early COPD for China Pulmonary Health Study Stage II
Physiotherapy Treatment Plan in Allergic Bronchopulmonary Aspergillosis: Case Report
Comparison of Respiratory Muscle, Pain, Functional Performance and Cognitive Status in Obstructive Lung Diseases
A Cohort of Patients With Chronic Pulmonary Disease
A Study to Evaluate the Effect of Yoga Exercises and Meditation on Lung Function and Quality of Life in COPD Patients.
Inhaler Technique Training